- Home
- ARDX vs CRAI Comparison
ARDX vs CRAI Comparison
Compare ARDX & CRAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDX
- CRAI
- Stock Information
- Founded
- ARDX 2007
- CRAI 1965
- Country
- ARDX United States
- CRAI United States
- Employees
- ARDX N/A
- CRAI N/A
- Industry
- ARDX Biotechnology: Pharmaceutical Preparations
- CRAI Other Consumer Services
- Sector
- ARDX Health Care
- CRAI Consumer Discretionary
- Exchange
- ARDX Nasdaq
- CRAI Nasdaq
- Market Cap
- ARDX 1.4B
- CRAI 1.2B
- IPO Year
- ARDX 2014
- CRAI 1998
- Fundamental
- Price
- ARDX $5.06
- CRAI $200.99
- Analyst Decision
- ARDX Buy
- CRAI Buy
- Analyst Count
- ARDX 8
- CRAI 1
- Target Price
- ARDX $9.93
- CRAI $212.00
- AVG Volume (30 Days)
- ARDX 3.6M
- CRAI 34.1K
- Earning Date
- ARDX 02-20-2025
- CRAI 02-20-2025
- Dividend Yield
- ARDX N/A
- CRAI 0.98%
- EPS Growth
- ARDX N/A
- CRAI 25.05
- EPS
- ARDX N/A
- CRAI 6.74
- Revenue
- ARDX $333,615,000.00
- CRAI $687,414,000.00
- Revenue This Year
- ARDX $169.30
- CRAI $10.80
- Revenue Next Year
- ARDX $14.87
- CRAI $3.40
- P/E Ratio
- ARDX N/A
- CRAI $29.82
- Revenue Growth
- ARDX 168.06
- CRAI 10.17
- 52 Week Low
- ARDX $4.32
- CRAI $111.20
- 52 Week High
- ARDX $9.83
- CRAI $214.01
- Technical
- Relative Strength Index (RSI)
- ARDX 41.70
- CRAI 58.98
- Support Level
- ARDX $5.37
- CRAI $187.88
- Resistance Level
- ARDX $6.55
- CRAI $214.01
- Average True Range (ATR)
- ARDX 0.31
- CRAI 6.43
- MACD
- ARDX -0.02
- CRAI 1.70
- Stochastic Oscillator
- ARDX 0.67
- CRAI 61.46
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.
About CRAI CRA International Inc.
CRA International Inc is a U.S.-based advisory firm that provides economic, financial, and management consultancy services. The company advises clients on economic and financial issues relating to litigation and regulatory proceedings and helps businesses set important business strategies and solve performance-related issues. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. CRA International generates majority of its revenue from the United States.